Fluorescent ligands for GPCR arrays
AssigneeCorning Incorporated, Patent Dept.
InventorsYe Fang, Yulong Hong, Jinlin Peng
Life of this patent
Estimating the term…
Loading patent…
AssigneeCorning Incorporated, Patent Dept.
InventorsYe Fang, Yulong Hong, Jinlin Peng
Estimating the term…
Microarrays employing a fluorescent ligand including a material having a binding affinity in the range of about 0.01 to about 25 nM, or about 0.1 to about 10 nM; a specificity to its cognate receptor in the range of about 50 to about 99%, or about 65 to about 99%; a cross-activity to other receptors of 0 to about 20%, or 0 to about 10%; a net charge per ligand of about −3 to about +5, or more preferably, about −2 to about +2 or most preferably for small compound ligands about −1 to about +2. The ligand may also have a hydrophobicity in the range of about 3 to about 55 minutes eluting time (as measured under specified eluting conditions). In some embodiments, the ligand includes fluorescently labeled motilin 1-16 labeled with Bodipy-TMR, rhodamine or Cy5-. Other embodiments include fluorescently labeled Cy5-naltrexone, Cy5-neurotensin 2-13, N-terminal labeled neurotensin 2-13 or lys-labeled labeled neurotensin 2-13.
A system for screening target compounds comprising:
A microarray comprising a plurality of GPCR microspots associated with a surface of a substrate coated with a γ-aminopropylsilane, the microarray adapted to receive at least one fluorescently labeled ligand for contacting said microspots comprising fluorescently labeled motilin 1-16 having a binding affinity in the range of about 0.01 to about 25 nM, a specificity to its cognate receptor in the range of about 50 to about 99%;
Dependencies are inferred from the claim text.